| 1 |
赵平，陈万青.2010中国肿瘤登记年报[M]．北京：军事医学科学出版社，2010.
|
| 2 |
Rim S H, Seeff L, Ahmed F，et al.Colorectal cancer incidence in the United States，1999-2004：An updated analysis of data from the National Program of Cancer Registries and the Surveillance，Epidemiology，and End Results Program[J]．Cancer，2009，115(9):1967-1976.
|
| 3 |
Johns LE, Houlston RS.A systematic review and meta-analysis of familial prostate cancer risk[J]．Bju International，2015，91(9):789-794.
|
| 4 |
Chen H M, Weng Y R, Jiang B，et al.Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009[J]．J Dig Dis，2011，12(5):371-378.
|
| 5 |
O′Hare A, Fenlon H．Virtual colonoscopy in the detection of colonic polyps and neoplasms[J]．Best Pract Res Clin Gastroenterol，2006，20(1):79-92.
|
| 6 |
Gutfeld, O.Expression of Serum Amyloid A，in Normal，Dysplastic，and Neoplastic Human Colonic Mucosa：Implication for a Role in Colonic Tumorigenesis[J]．J Histochem Cytochemistry，2006，54(1):63-73.
|
| 7 |
Sherwood RA.Faecal markers of gastrointestinal inflammation[J]．J Clin Pathol，2012，65(11):981-985.
|
| 8 |
Magdalena KM, MaGorzata W, Eugeniusz JK.Calprotectin in rheumatic diseases：a review[J]．Reumatologia/Rheumatology，2016，6:306-309.
|
| 9 |
Roseth AG, Schmidt PN, Fagerhol MK.Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin，a granulocyte marker protein，in patients with inflammatory bowel disease[J]．Scand J Gastroenterol，1999，34:50-54.
|
| 10 |
Tibble J．A simple method for assessing intestinal inflammation in Crohn\" s disease[J]．Gut，2000，47(4):506-513.
|
| 11 |
Tibble JA, Bjarnason I．Non-invasive investigation of inflammatory bowel disease[J]．World J Gastroenterol，2001，7(4):460-465.
|
| 12 |
Vogl T, Tenbrock K, Ludwig S，et al.Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4，promoting lethal，endotoxin-induced shock[J]．Nature Medicine，2007，13(9):1042-1049.
|
| 13 |
Ayling RM, Kok K．Fecal Calprotectin[J]．Adv Clin Chem，2018，87:161-190.
|
| 14 |
Dhaliwal A, Zeino Z, Tomkins C，et al.Utility of faecal calprotectin in inflammatory bowel disease(IBD)：what cut-offs should we apply？[J]．Frontline Gastroenterology，2015，6(1):14-19.
|
| 15 |
Lasson A, Stotzer P O, Öhman, Lena，et al.The intra-individual variability of faecal calprotectin：A prospective study in patients with active ulcerative colitis[J]．J Crohns Colitis，2015，9(1):26-32.
|
| 16 |
Dhaliwal A, Zeino Z, Tomkins C，et al.Utility of fecal calprotectin in inflammatory bowel disease(IBD)：what cut-offs should we apply？[J]．Frontline Gastroenterology，2015，6(1):14-19.
|
| 17 |
Ricciuto A．Clinical value of fecal calprotectin.Crit Rev Clin Lab Sci，2019，56:307-320.
|
| 18 |
Coorevits L, Baert FJ, Vanpoucke HJM.Fecal calprotectin：comparative study of the Quantum Blue rapid test and an established ELISA method[J]．Clinical Chemistry and Laboratory Medicine，2013，51(4):825-831.
|
| 19 |
Labaere D, Smismans A, Van Olmen A，et al.Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease[J]．United European Gastroenterology Journal，2014，2(1):30-37.
|
| 20 |
Kaiser T, Langhorst J, Wittkowski H，et al.Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome[J]．Gut，2007，56(12):1706-1713.
|
| 21 |
Caviglia GP, Pantaleoni S, Touscoz GA，et al.Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders[J]．Scand J Gastroenterol，2014，49(12):1419-1424.
|
| 22 |
Caviglia GP, Ribaldone DG, Rosso C，et al.Fecal calprotectin：beyond intestinal organic diseases[J]．Panminerva Med，2018，60(1):29-34.
|
| 23 |
Pezzilli R, Barassi A, Labate A MM，et al.Fecal Calprotectin Levels in Patients with Colonic Polyposis[J]．Dig Dis Scis，2008，53(1):47-51.
|
| 24 |
Tibble J．Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma[J]．Gut，2001，49(3):402-408.
|
| 25 |
杨洁．粪便钙卫蛋白检测在结直肠癌诊断中的作用探究[J]．检验医学与临床，2016，13(14):1972-1974.
|
| 26 |
Luley K, Noack F, Lehnert H，et al.Local calprotectin production in colorectal cancer and polyps-active neutrophil recruitment in carcinogenesis[J]．Int J Colorectal Dis，2011，26(5):603-607.
|
| 27 |
Damms A, Bischoff SC.Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases[J]．Intl J Colorectal Dis，2008，23(10):985-992.
|
| 28 |
Fox V L, Perros S, Jiang H，et al.Juvenile polyps：recurrence in patients with multiple and solitary polyps.[J]．Clin Gastroenterol Hepatol，2010，8(9):795-799.
|
| 29 |
Pauley-Hunter RJ, Kunnath S, Wolff K，et al.Fecal Calprotectin and Pediatric Juvenile Polyps[J]．J Pediatr Gastroenterol Nutr，2015，60(4):30-1.
|
| 30 |
Olafsdottir I, Nemeth A, Lörinc, Ester，et al.Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy[J]．J Pediatr Gastroenterol Nutr，2016，62(1):43.
|
| 31 |
Hodgson-Parnell L, Spence O．Solitary juvenile polyp as a cause of elevated faecal calprotectin in an adult[J]．BMJ Case Rep，2018，2018.
|